Dana Stenger

533 total citations
10 papers, 357 citations indexed

About

Dana Stenger is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Dana Stenger has authored 10 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Dana Stenger's work include CAR-T cell therapy research (10 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Virus-based gene therapy research (3 papers). Dana Stenger is often cited by papers focused on CAR-T cell therapy research (10 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Virus-based gene therapy research (3 papers). Dana Stenger collaborates with scholars based in Germany and United States. Dana Stenger's co-authors include Semjon Willier, Tobias Feuchtinger, Franziska Blaeschke, Theresa Kaeuferle, Ramin Lotfi, Mario Assenmacher, Judith Feucht, Andrew Kaiser, Michaela Döring and Sebastian Kobold and has published in prestigious journals such as Blood, Frontiers in Immunology and Leukemia.

In The Last Decade

Dana Stenger

8 papers receiving 353 citations

Peers

Dana Stenger
Silvia Arcangeli Italy
Maria Caterina Rotiroti Italy
Vania Aikawa United States
Deanna Langfitt United States
Edward Waldron United States
Zhuojun Ling China
Jolanta Stefanski United States
Claudia Diamonte United States
Alex H. Chang China
Annie Etuk United Kingdom
Silvia Arcangeli Italy
Dana Stenger
Citations per year, relative to Dana Stenger Dana Stenger (= 1×) peers Silvia Arcangeli

Countries citing papers authored by Dana Stenger

Since Specialization
Citations

This map shows the geographic impact of Dana Stenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Stenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Stenger more than expected).

Fields of papers citing papers by Dana Stenger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Stenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Stenger. The network helps show where Dana Stenger may publish in the future.

Co-authorship network of co-authors of Dana Stenger

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Stenger. A scholar is included among the top collaborators of Dana Stenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Stenger. Dana Stenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kaeuferle, Theresa, Reinhard Zeidler, Semjon Willier, et al.. (2025). All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasone. Experimental Hematology and Oncology. 14(1). 40–40.
2.
Willier, Semjon, J L Farber, Dana Stenger, et al.. (2023). CD28 CAR T Cells for the Treatment of T Cell Malignancies. Blood. 142(Supplement 1). 3448–3448. 1 indexed citations
3.
Blaeschke, Franziska, Dana Stenger, Theresa Kaeuferle, et al.. (2022). Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function. Frontiers in Immunology. 13. 845499–845499. 12 indexed citations
4.
Kaeuferle, Theresa, Stefan Canzar, Semjon Willier, et al.. (2022). Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells. Clinical & Translational Immunology. 11(1). e1372–e1372. 8 indexed citations
5.
Blaeschke, Franziska, Semjon Willier, Dana Stenger, et al.. (2020). Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients. Leukemia. 34(10). 2607–2620. 33 indexed citations
6.
Willier, Semjon, Maximilian Hastreiter, Dana Stenger, et al.. (2020). CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy. Blood. 137(8). 1037–1049. 55 indexed citations
7.
Stenger, Dana, Theresa Kaeuferle, Semjon Willier, et al.. (2020). Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR. Blood. 136(12). 1407–1418. 123 indexed citations
8.
Willier, Semjon, Franziska Blaeschke, Dana Stenger, et al.. (2020). Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells. Journal for ImmunoTherapy of Cancer. 8(2). e001052–e001052. 7 indexed citations
9.
10.
Willier, Semjon, Dana Stenger, Theresa Kaeuferle, et al.. (2018). Bone Marrow T Cells Are Driven into Exhaustion By Acute Leukemia in Pediatric Patients Based on Protein and Transcriptome Analysis. Blood. 132(Supplement 1). 3722–3722.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Arcangeli Breakdown of academic impact, for papers by Maria Caterina Rotiroti Breakdown of academic impact, for papers by Vania Aikawa Breakdown of academic impact, for papers by Deanna Langfitt Breakdown of academic impact, for papers by Edward Waldron Breakdown of academic impact, for papers by Zhuojun Ling Breakdown of academic impact, for papers by Jolanta Stefanski Breakdown of academic impact, for papers by Claudia Diamonte Breakdown of academic impact, for papers by Alex H. Chang Breakdown of academic impact, for papers by Annie Etuk
Rankless by CCL
2026